Mega-trials and management of acute myocardial infarction (Q40468897)

20 September 2017

1 reference

title

Mega-trials and management of acute myocardial infarction (English)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

17 July 2024

author name string

K. L. Woods

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:7651008

17 July 2024

language of work or name

English

0 references

publication date

1 September 1995

1 reference

20 September 2017

2 September 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7651008

full work available at URL

17 July 2024

https://api.elsevier.com/content/article/PII:S0140673695914404?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

https://api.elsevier.com/content/article/PII:S0140673695914404?httpAccept=text/plain

17 July 2024

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

17 July 2024

1 reference

20 September 2017

volume

346

1 reference

20 September 2017

issue

8975

1 reference

20 September 2017

page(s)

611-614

1 reference

Why do we need some large, simple randomized trials?

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

1 reference

7 January 2021

Myocardial infarction: ACE inhibitors for all? For ever?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

ACE inhibition in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Effects of magnesium supplementation in a porcine model of myocardial ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Magnesium treatment of acute myocardial infarction: effects on necrosis in an occlusion/reperfusion dog model

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Magnesium and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Beneficial effect of magnesium on the isolated perfused rat heart during reperfusion after ischaemia: comparison between pre-ischaemic and post-ischaemic administration of magnesium

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Mechanism of myocardial "stunning".

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Myocardial stunning--are calcium antagonists useful?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

ACE inhibition after myocardial infarction: can megatrials provide answers?

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Predictive ability of meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

7 January 2021

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

series ordinal

10

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(95)91440-4

17 July 2024

Identifiers

1 reference

20 September 2017

1 reference